Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD

Clinical trial NCT01207622 · WITHDRAWN

Trial details

NCT number: NCT01207622
Sponsor: Massachusetts General Hospital
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Substance Use Disorder

Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.